RecruitingNCT04114435
Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants: A Prospective Cross-sectional Study
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment
150 participants
Start Date
Oct 12, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
Pulmonary vascular disease and cardiac performance in extreme preterm infants: A prospective cross-sectional study
Eligibility
Min Age: 7 DaysMax Age: 5 Years
Inclusion Criteria2
- Infants born at \<29 weeks' gestational age admitted to the NICU
- All infants born at \<29 weeks' gestational age followed at MCH clinic after an admission in the NICU for prematurity \<29 weeks
Exclusion Criteria3
- Congenital heart disease (except an atrial (ASD) or ventricular septal defect (VSD), or a patent ductus arteriosus (PDA))
- Congenital severe lung or airway malformation (choanal atresia, trachea-esophageal fistula or congenital pulmonary airway malformation)
- Genetic disorder (Trisomy 21).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHEREchocardiography
Diagnostic test which uses ultrasound waves to make images of the heart chambers, valves and surrounding structures
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04114435
Related Trials
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).
NCT071923937 locations
Targeted Fortification of Donor Breast Milk in Preterm Infants
NCT042943681 location
Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial
NCT065575511 location